![](https://blog.roundhillinvestments.com/hs-fs/hubfs/OZEMBlog3.png?width=480&name=OZEMBlog3.png)
In-Network Stocks for OZEM
Originally developed for diabetes treatment, the discovery of GLP-1 therapeutics as a weight loss...
For all other registered brokerages, contact them directly to invest.
Posts by
Dave MazzaDave is the Chief Executive Officer at Roundhill Investments. Previously, he was Managing Director, Head of Product, at Direxion, where he led the research and development of new products and the ongoing product management and strategy for the firm, as well as overseeing the firm's strategic partner relationships. Mazza brings over 15 years of ETF and asset management experience, across previous leadership roles with OppenheimerFunds and State Street SPDR ETFs.